RAD001; 42-O-(2-hydroxyethyl)-rapamycin
159351-69-6
958.2
C53H83NO14
DMF, DMSO, Ethanol
-20°C
Everolimus is a derivative of the macrolide Rapamycin (Cat. No. 1568-5, 50) that acts as an immunosuppressant, mTOR inhibitor and anticancer agent. It targets the raptor mammalian target of rapamycin (mTORC1).
0.1 lbs
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:Coahibitor; FUT 175; Nafamastat
CAS Number:82956-11-4
Substance Name:BSA fraction V
CAS Number:9048-46-8
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:NSC 79534; sodium vanadium oxide
CAS Number:13721-39-6
Substance Name:NSC 79534; sodium vanadium oxide
CAS Number:13721-39-6
